Can-Fite BioPharma Ltd. Financing Cash Flow
Can-Fite BioPharma Ltd. (CANF) reported Financing Cash Flow of $9.64 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-03-26
| Period end | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|
| 2025-12-31 | $9.64M 20-F · filed 2026-03-26 | |
| 2025-06-30 | $3.37M 6-K · filed 2025-08-28 | |
| 2024-12-31 | $6.71M 20-F · filed 2026-03-26 | |
| 2023-12-31 | $9.14M 20-F · filed 2026-03-26 | |
| 2023-06-30 | $6.53M 6-K · filed 2024-08-29 | |
| 2021-12-31 | $20.46M 20-F · filed 2024-03-28 | |
| 2021-06-30 | $2.74M 6-K · filed 2022-08-25 | |
| 2020-12-31 | $17.68M 20-F · filed 2023-03-30 | |
| 2020-06-30 | $14.85M 6-K · filed 2021-08-26 | |
| 2019-12-31 | $10.17M 20-F · filed 2022-03-24 | |
| 2019-06-30 | $10.17M 6-K · filed 2020-08-27 | |
| 2018-12-31 | $4.39M 20-F · filed 2021-03-25 | |
| 2017-12-31 | $4.47M 6-K · filed 2020-06-01 |